Torthaí cuardaigh - Vladimir Tolmachev

Beachtaigh na torthaí
  1. 1
    Affibody Molecules as Targeting Vectors for PET Imaging

    Affibody Molecules as Targeting Vectors for PET Imaging de réir Vladimir Tolmachev, Anna Orlova

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Methods for Radiolabelling of Monoclonal Antibodies

    Methods for Radiolabelling of Monoclonal Antibodies de réir Vladimir Tolmachev, Anna Orlova, Karl Andersson

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    On the Selection of a Tracer for PET Imaging of HER2-Expressing Tumors: Direct Comparison of a <sup>124</sup>I-Labeled Affibody Molecule and Trastuzumab in a Murine Xenograft Model

    On the Selection of a Tracer for PET Imaging of HER2-Expressing Tumors: Direct Comparison of a <sup>124</sup>I-Labeled Affibody Molecule and Trastuzumab in a Murine Xenograft Model de réir Anna Orlova, Helena Wållberg, Sharon Stone‐Elander, Vladimir Tolmachev

    Foilsithe / Cruthaithe 2009
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Imaging using radiolabelled targeted proteins: radioimmunodetection and beyond

    Imaging using radiolabelled targeted proteins: radioimmunodetection and beyond de réir Javad Garousi, Anna Orlova, Fredrik Y. Frejd, Vladimir Tolmachev

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Affibody molecules: Engineered proteins for therapeutic, diagnostic and biotechnological applications

    Affibody molecules: Engineered proteins for therapeutic, diagnostic and biotechnological applications de réir John Löfblom, Joachim Feldwisch, Vladimir Tolmachev, J. Carlsson, S. Ståhl, Fredrik Y. Frejd

    Foilsithe / Cruthaithe 2010
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Tumor Targeting Using Affibody Molecules: Interplay of Affinity, Target Expression Level, and Binding Site Composition

    Tumor Targeting Using Affibody Molecules: Interplay of Affinity, Target Expression Level, and Binding Site Composition de réir Vladimir Tolmachev, Thuy Tran, Daniel Rosik, Anna Sjöberg, Lars Abrahmsén, Anna Orlova

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Extending Half-life by Indirect Targeting of the Neonatal Fc Receptor (FcRn) Using a Minimal Albumin Binding Domain

    Extending Half-life by Indirect Targeting of the Neonatal Fc Receptor (FcRn) Using a Minimal Albumin Binding Domain de réir Jan Terje Andersen, Rikard Pehrson, Vladimir Tolmachev, Muluneh Bekele Daba, Lars Abrahmsén, Caroline Ekblad

    Foilsithe / Cruthaithe 2010
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Affibody-mediated PET imaging of HER3 expression in malignant tumours

    Affibody-mediated PET imaging of HER3 expression in malignant tumours de réir Maria� Rosestedt, Karl Andersson, Bogdan Mitran, Vladimir Tolmachev, John Löfblom, Anna Orlova, Stefan Ståhl

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Selection and characterization of HER2/neu-binding affibody ligands

    Selection and characterization of HER2/neu-binding affibody ligands de réir Maria Wikman, A.-C. Steffen, Elin Gunneriusson, Vladimir Tolmachev, Gregory P. Adams, J. Carlsson, S. Ståhl

    Foilsithe / Cruthaithe 2004
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Feasibility of Affibody Molecule-Based PNA-Mediated Radionuclide Pretargeting of Malignant Tumors

    Feasibility of Affibody Molecule-Based PNA-Mediated Radionuclide Pretargeting of Malignant Tumors de réir Hadis Honarvar, Kristina Westerlund, Mohamed Altai, Mattias Sandström, Anna Orlova, Vladimir Tolmachev, Amelie Eriksson Karlström

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    Influence of Nuclides and Chelators on Imaging Using Affibody Molecules: Comparative Evaluation of Recombinant Affibody Molecules Site-Specifically Labeled with <sup>68</sup>Ga and <sup>111</sup>In via Maleimido Derivatives of DOTA and NODAGA

    Influence of Nuclides and Chelators on Imaging Using Affibody Molecules: Comparative Evaluation of Recombinant Affibody Molecules Site-Specifically Labeled with <sup>68</sup>Ga and... de réir Mohamed Altai, Joanna Strand, Daniel Rosik, Ram Kumar Selvaraju, Amelie Eriksson Karlström, Anna Orlova, Vladimir Tolmachev

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    Influence of Macrocyclic Chelators on the Targeting Properties of 68Ga-Labeled Synthetic Affibody Molecules: Comparison with 111In-Labeled Counterparts

    Influence of Macrocyclic Chelators on the Targeting Properties of 68Ga-Labeled Synthetic Affibody Molecules: Comparison with 111In-Labeled Counterparts de réir Joanna Strand, Hadis Honarvar, Anna Perols, Anna Orlova, Ram Kumar Selvaraju, Amelie Eriksson Karlström, Vladimir Tolmachev

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    Molecular Design and Optimization of <sup>99m</sup>Tc-Labeled Recombinant Affibody Molecules Improves Their Biodistribution and Imaging Properties

    Molecular Design and Optimization of <sup>99m</sup>Tc-Labeled Recombinant Affibody Molecules Improves Their Biodistribution and Imaging Properties de réir Helena Wållberg, Anna Orlova, Mohammed Altai, Seyed Jalal Hosseinimehr, Charles Widström, Jennie Malmberg, Stefan Ståhl, Vladimir Tolmachev

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    Molecular Imaging of <i>HER2</i>-Expressing Malignant Tumors in Breast Cancer Patients Using Synthetic <sup>111</sup>In- or <sup>68</sup>Ga-Labeled Affibody Molecules

    Molecular Imaging of <i>HER2</i>-Expressing Malignant Tumors in Breast Cancer Patients Using Synthetic <sup>111</sup>In- or <sup>68</sup>Ga-Labeled Affibody Molecules de réir Richard P. Baum, Vikas Prasad, Dirk Müller, Christiane Schuchardt, Anna Orlova, Anders Wennborg, Vladimir Tolmachev, Joachim Feldwisch

    Foilsithe / Cruthaithe 2010
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    Locally Delivered CD40 Agonist Antibody Accumulates in Secondary Lymphoid Organs and Eradicates Experimental Disseminated Bladder Cancer

    Locally Delivered CD40 Agonist Antibody Accumulates in Secondary Lymphoid Organs and Eradicates Experimental Disseminated Bladder Cancer de réir Linda C. Sandin, Anna Orlova, Erika Gustafsson, Peter Ellmark, Vladimir Tolmachev, Thomas H. Tötterman, Sara M. Mangsbo

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    PET imaging of epidermal growth factor receptor expression in tumours using 89Zr-labelled ZEGFR:2377 affibody molecules

    PET imaging of epidermal growth factor receptor expression in tumours using 89Zr-labelled ZEGFR:2377 affibody molecules de réir Javad Garousi, Karl Andersson, Bogdan Mitran, MARIE-LOUISE PICHL, Stefan Ståhl, Anna Orlova, John Löfblom, Vladimir Tolmachev

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    Imaging of Insulinlike Growth Factor Type 1 Receptor in Prostate Cancer Xenografts Using the Affibody Molecule<sup>111</sup>In-DOTA-Z<sub>IGF1R:4551</sub>

    Imaging of Insulinlike Growth Factor Type 1 Receptor in Prostate Cancer Xenografts Using the Affibody Molecule<sup>111</sup>In-DOTA-Z<sub>IGF1R:4551</sub> de réir Vladimir Tolmachev, Jennie Malmberg, Camilla Hofström, Lars Abrahmsén, Thomas Bergman, Anna Sjöberg, Mattias Sandström, Torbjörn Gräslund, Anna Orlova

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    Intra-image referencing for simplified assessment of HER2-expression in breast cancer metastases using the Affibody molecule ABY-025 with PET and SPECT

    Intra-image referencing for simplified assessment of HER2-expression in breast cancer metastases using the Affibody molecule ABY-025 with PET and SPECT de réir Dan Sandberg, Vladimir Tolmachev, Irina Velikyan, Helena Olofsson, Anders Wennborg, Joachim Feldwisch, Jörgen Carlsson, Henrik Lindman, Jens Sörensen

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    HAHAHA, HEHEHE, HIHIHI, or HKHKHK: Influence of Position and Composition of Histidine Containing Tags on Biodistribution of [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-Labeled Affibody Molecules

    HAHAHA, HEHEHE, HIHIHI, or HKHKHK: Influence of Position and Composition of Histidine Containing Tags on Biodistribution of [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-Labeled A... de réir Camilla Hofström, Mohamed Altai, Hadis Honarvar, Joanna Strand, Jennie Malmberg, Seyed Jalal Hosseinimehr, Anna Orlova, Torbjörn Gräslund, Vladimir Tolmachev

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 20
    Pharmacokinetics and red cell utilization of iron(III) hydroxide–sucrose complex in anaemic patients: a study using positron emission tomography

    Pharmacokinetics and red cell utilization of iron(III) hydroxide–sucrose complex in anaemic patients: a study using positron emission tomography de réir Soheir Beshara, Hans Lundqvist, Johanna Sundin, Mark Lubberink, Vladimir Tolmachev, Sven Valind, Gunnar Antoni, Bengt Långström, Bo G. Danielson

    Foilsithe / Cruthaithe 1999
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: